Domino's Pizza Enterprises Ltd. keeps making the dough: But is it too expensive?

Is Domino's Pizza Enterprises Ltd. (ASX:DMP) one to gobble up, or is the valuation now too excessive?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Domino's Pizza Enterprises Ltd. (ASX: DMP) delivered another brilliant year for shareholders with net profit up more than 50% on the prior year to $45.8 million. A final fully franked dividend of 19 cents per share was declared, taking the full year total to 36.7 cents and placing the stock on a yield of 1.58% when selling for $23.26.

Same-store sales growth in its core Australia and New Zealand market was 6.3%, but investors are looking east to the mega-market of Japan for the new chapter in an impressive growth story. Some financial analysts thought the Japanese consumer market with different dietary inclinations may prove a bridge too far in developing the story. However, it appears the allure of well marketed and cheap pizza has proven irresistible even in Japan, with earnings there up 70% on the prior corresponding period and now contributing almost one the group's total.

So with Domino's smashing through 52-week highs with more regularity than some get through the pizzas, is it to time to buy, or might there be some chinks in the armour?

Well the current valuation is certainly fruity, selling for $23.26 Domino's trades on 46 times earnings, meaning today's buyers are expecting it to gobble up the Japanese market and keep delivering strong same store sales growth in Australia.

While the overall key to Domino's success appears to be its ability to make a profit while selling its pizzas far cheaper than competitors. If a low-cost competitor were able to steal market share then Domino's may feel the heat, otherwise with a seemingly top-notch management team delivering on strategy and execution it could justify today's valuation.

However, paying too much for fast-growing companies is one of the commonest investing mistakes to avoid and buyer's at today prices may find slim pickings in future returns. Personally, I would not be chasing Domino's at these valuations, although the growth story remains positive, it may find the domestic market gets increasingly crowded.

Motley Fool contributor Tom Richardson has no financial interest in any company mentioned. You can find him on Twitter @tommyr345

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »